Seeking Alpha

Discovery Labs (DSCO) announces FDA approval for Surfaxin. The company anticipates that the...

Discovery Labs (DSCO) announces FDA approval for Surfaxin. The company anticipates that the treatment for respiratory illness in infants will be commercially available in the U.S. in late 2012. Shares are halted AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)